Quest Diagnostics proposes $1,250,000,000 senior notes offering

Quest Diagnostics Incorporated (the "Company") (NYSE:  DGX), the world's leading provider of diagnostic testing, information and services, announced today that it intends to offer $1,250,000,000 in aggregate principal amount of four series of senior notes in a public offering made under a shelf registration statement filed with the Securities and Exchange Commission, subject to market and other conditions.  The notes will be fully and unconditionally guaranteed on a senior, unsecured basis by certain of the Company's domestic, wholly owned subsidiaries.

The issuance of the notes will be subject to customary closing conditions.  The Company intends to use the net proceeds from the offering to fund the purchase price and related transaction costs of its acquisition of Athena Diagnostics, Inc. and to repay outstanding indebtedness under its senior unsecured revolving credit facility and secured receivables credit facility.  Morgan Stanley & Co. Incorporated, Goldman, Sachs & Co., RBS Securities Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC will be joint bookrunning managers for the debt offering.  When available, copies of the preliminary prospectus supplement and the accompanying base prospectus for the offering can be obtained from Morgan Stanley & Co. Incorporated tollfree at (866) 7181649, Goldman, Sachs & Co. tollfree at (866) 471-2526, RBS Securities Inc. tollfree at (866) 8842071, J.P. Morgan Securities LLC at (212) 834-4533 and Wells Fargo Securities, LLC toll-free at (800) 326-5897.

SOURCE Quest Diagnostics Incorporated

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Quest Diagnostics. (2011, March 21). Quest Diagnostics proposes $1,250,000,000 senior notes offering. News-Medical. Retrieved on May 24, 2024 from https://www.news-medical.net/news/20110321/Quest-Diagnostics-proposes-241250000000-senior-notes-offering.aspx.

  • MLA

    Quest Diagnostics. "Quest Diagnostics proposes $1,250,000,000 senior notes offering". News-Medical. 24 May 2024. <https://www.news-medical.net/news/20110321/Quest-Diagnostics-proposes-241250000000-senior-notes-offering.aspx>.

  • Chicago

    Quest Diagnostics. "Quest Diagnostics proposes $1,250,000,000 senior notes offering". News-Medical. https://www.news-medical.net/news/20110321/Quest-Diagnostics-proposes-241250000000-senior-notes-offering.aspx. (accessed May 24, 2024).

  • Harvard

    Quest Diagnostics. 2011. Quest Diagnostics proposes $1,250,000,000 senior notes offering. News-Medical, viewed 24 May 2024, https://www.news-medical.net/news/20110321/Quest-Diagnostics-proposes-241250000000-senior-notes-offering.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Majority of American adults use prescription drugs inappropriately and dangerously